NFATC2 (nuclear factor of activated T cells 2) is a calcium-dependent transcription factor that plays critical roles in immune cell function and cellular differentiation. Its primary function involves regulating cytokine gene expression in T cells, particularly IL-2, IL-3, IL-4, TNF, and GM-CSF 1. The protein is activated through the calcium/calmodulin-dependent phosphatase calcineurin pathway, which controls its translocation from cytoplasm to nucleus 1. NFATC2 contains a DNA-binding domain similar to Rel-family proteins and can cooperatively bind with AP-1 transcription factors to composite regulatory elements 1. In CD8+ T cells, NFATC2 activation is essential for effector function and prevents T cell exhaustion, with competent activation protecting against dysfunction despite inducing checkpoint receptors like Tim3 2. The protein also regulates metabolic signaling, where early methionine availability affects NFATC2 activation and subsequent T cell fate decisions 3. Beyond immune function, NFATC2 contributes to cancer biology, being implicated in melanoma cell state transitions 4 and neuroinflammation in Parkinson's disease through regulation of type I interferon responses 5. Additionally, NFATC2 appears to suppress osteochondroma formation, with reduced expression observed in human osteochondroma samples 6. Clinically, NFATC2 represents a potential therapeutic target for enhancing anti-tumor immunity and treating immune-related disorders.